MultiKano is the first automatic cell type annotation method tailored to single-cell multi-omics data. MultiKano introduces a novel data augmentation strategy based on paired scRNA-seq and scATAC ...

While the process via which different types of neurons are produced, also known as neurogenesis, has been the focus of ...

Researchers at VCU Massey Comprehensive Cancer Center have developed a new computational tool called Vesalius, which could ...

Vertex Pharmaceuticals is stopping development of VX-264, an experimental cell therapy/medical device treatment for type 1 diabetes, after an early look at Phase 1/2 data fell short of efficacy ...

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of ...

Data were derived from Rickels MR, et al. Improvement in glycemic control and elimination of exogenous insulin use in patients with type 1 diabetes infused with fully differentiated islet cells ...

Sana Biotechnology will present clinical data on UP421, a hypoimmune islet cell therapy for type 1 diabetes, at an upcoming symposium.

Zymeworks presents six posters at AACR highlighting advancements in antibody-drug conjugates and T cell engagers, including ZW209's promise in lung cancer.

Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature ...

An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.